保留下肢肌肉量可预防非糖尿病老年人发生胰岛素抵抗
该研究基于2017-2019年Tanno-Sobetsu前瞻性队列中194名≥65岁非糖尿病社区老年人,基线用生物电阻抗法测四肢及躯干肌肉量、握力、伸膝力矩和步速,随访至多2年,终点为HOMA-IR≥1.73。结果显示下肢肌肉量(HR 0.88,95%CI 0.79-0.98)和四肢肌肉量(HR 0.89,95%CI 0.81-0.99)与胰岛素抵抗发生独立相关,其他肌少症组分无此关联。
要点
- 下肢肌肉量每增加一个单位,胰岛素抵抗发生风险降低(HR 0.88,95%CI 0.79-0.98)。
- 四肢肌肉量亦与胰岛素抵抗发生独立负相关(HR 0.89,95%CI 0.81-0.99)。
- 握力、伸膝力矩、步速及上肢/躯干肌肉量未显示与胰岛素抵抗发生独立关联。
核心结论
- 下肢肌肉量丢失是非糖尿病老年人发生胰岛素抵抗的显著危险因素,且独立于肥胖。
- 下肢肌肉量可能成为预防老年人糖尿病的新干预靶点。
研究设计与样本
- 为期2年的随访队列研究,数据来自Tanno-Sobetsu前瞻性观察队列。
- 纳入2017-2019年194名社区居住的非糖尿病老年人(79名男性、115名女性),年龄≥65岁。
主要发现
- 下肢肌肉量(HR 0.88,95%CI 0.79-0.98)和四肢肌肉量(HR 0.89,95%CI 0.81-0.99)与胰岛素抵抗发生独立相关。
- 其他肌少症组分(上肢肌肉量、躯干肌肉量、握力、伸膝力矩、步速)未显示与胰岛素抵抗发生独立关联。
- 上述关联独立于性别、年龄、基线HOMA-IR和腰围。
关键数值与推荐
- 基线HOMA-IR<1.73的非糖尿病老年人进入随访,终点为HOMA-IR≥1.73定义为胰岛素抵抗发生。
- 肌肉量经生物电阻抗法测量,肌肉量和力量除以体重后乘以100计算体重比值(%)。
临床怎么用
- 在非糖尿病老年人中,评估下肢肌肉量有助于识别胰岛素抵抗高风险个体。
- 针对下肢肌肉量的干预可能作为预防老年人糖尿病的策略方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate roles of sarcopenia indexes in prediction of development of insulin resistance in nondiabetic older adults. DESIGN: A 2-year follow-up cohort. SETTING AND PARTICIPANTS: The Tanno-Sobetsu study, a prospective observational cohort, included 194 community-dwelling nondiabetic older adults during 2017-2019. METHODS: Lower limb, upper limb, appendicular, and trunk muscle masses by a bioelectrical impedance analysis, grip strength, knee extension torque, and walking speed were measured in study participants aged ≥65 years (79 men and 115 women) at baseline. Muscle mass and strength were divided by the weight, and then multiplied by 100 to calculate the weight ratio (%). Insulin resistance was assessed by homeostasis model (HOMA-IR) at baseline, and the study participants whose HOMA-IR was less than 1.73 at baseline were followed for a maximum of 2 years. The study endpoint was development of insulin resistance defined as HOMA-IR ≥1.73. The adjusted hazard ratio (HR) of each sarcopenia component for development of insulin resistance was calculated. RESULTS: Lower limb muscle mass (HR 0.88, 95% CI 0.79-0.98) and appendicular muscle mass (HR 0.89, 95% CI 0.81-0.99), but not other sarcopenia components, were associated with the development of insulin resistance, independently of sex and age, HOMA-IR, and waist circumference at baseline. CONCLUSIONS AND IMPLICATIONS: The loss of lower limb muscle mass is a significant risk factor for development of insulin resistance independently of obesity in nondiabetic older adults. The lower limb muscle mass may be a novel target of interventions for the prevention of diabetes in older adults.
引用
- Seko T, Akasaka H, Koyama M, et al. Preserved Lower Limb Muscle Mass Prevents Insulin Resistance Development in Nondiabetic Older Adults. J Am Med Dir Assoc. 2022. PMID: 36592939. doi:10.1016/j.jamda.2022.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。